Cargando…

The Role of FAS Receptor Methylation in Osteosarcoma Metastasis

Osteosarcoma is the most frequent primary malignant bone tumor with an annual incidence of about 400 cases in the United States. Osteosarcoma primarily metastasizes to the lungs, where FAS ligand (FASL) is constitutively expressed. The interaction of FASL and its cell surface receptor, FAS, triggers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jiayi M., Chow, Wing-Yuk, Xu, Gufeng, Hicks, M. John, Nakka, Manjula, Shen, Jianhe, Ng, Patrick Kwok Shing, Taylor, Aaron M., Yu, Alexander, Farrar, Jason E., Barkauskas, Donald A., Gorlick, Richard, Guidry Auvil, Jaime M., Gerhard, Daniela, Meltzer, Paul, Guerra, Rudy, Man, Tsz-Kwong, Lau, Ching C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418590/ https://www.ncbi.nlm.nih.gov/pubmed/37569529 http://dx.doi.org/10.3390/ijms241512155

Ejemplares similares

Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma
por: Nakka, Manjula, et al.
Publicado: (2017)

Integrated DNA Copy Number and Expression Profiling Identifies IGF1R as a Prognostic Biomarker in Pediatric Osteosarcoma
por: Taylor, Aaron M., et al.
Publicado: (2022)

Osteosarcoma enters a post genomic era with in silico opportunities: Generation of the High Dimensional Database for facilitating sarcoma biology research: A report from the Children's Oncology Group and the QuadW Foundation
por: Glover, Jason, et al.
Publicado: (2017)

Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma
por: Man, Tsz-Kwong, et al.
Publicado: (2004)

A systems biology approach reveals common metastatic pathways in osteosarcoma
por: Flores, Ricardo J, et al.
Publicado: (2012)

Prognostic and Therapeutic Utility of Variably Expressed Cell Surface Receptors in Osteosarcoma
por: Zvi, Yoav, et al.
Publicado: (2021)

Low expression of IGFBP4 and TAGLN accelerate the poor overall survival of osteosarcoma
por: Xi, Yue, et al.
Publicado: (2022)

MS-275 sensitizes osteosarcoma cells to Fas ligand-induced cell death by increasing the localization of Fas in membrane lipid rafts
por: Rao-Bindal, K, et al.
Publicado: (2012)

Mislocalized cytoplasmic p27 activates PAK1‐mediated metastasis and is a prognostic factor in osteosarcoma
por: Chen, Xiang, et al.
Publicado: (2020)

Phyllanthus urinaria Induces Apoptosis in Human Osteosarcoma 143B Cells via Activation of Fas/FasL- and Mitochondria-Mediated Pathways
por: Wu, Hsin-Yi, et al.
Publicado: (2012)

The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
por: Henkler, Frank, et al.
Publicado: (2005)

Apoptosis role of FAS/FAS ligand system in the regulation of myelopoiesis.
por: Alenzi, Faris Q., et al.
Publicado: (2005)

MSP-4, an Antimicrobial Peptide, Induces Apoptosis via Activation of Extrinsic Fas/FasL- and Intrinsic Mitochondria-Mediated Pathways in One Osteosarcoma Cell Line
por: Kuo, Hsiao-Mei, et al.
Publicado: (2018)

Variants of FasL and ABCC5 are predictive of outcome after chemotherapy-based treatment in osteosarcoma
por: Xu, Leilei, et al.
Publicado: (2018)

The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma
por: Ito, Y, et al.
Publicado: (2000)

Plasma concentrations of soluble Fas receptors (Fas) and Fas ligands (FasL) in relation to CD4+ cell counts in HIV-1 positive and negative patients in Yaounde, Cameroon
por: Ikomey, George M, et al.
Publicado: (2012)

Variability in the reported management of pulmonary metastases in osteosarcoma
por: Bhattasali, Onita, et al.
Publicado: (2015)

Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children’s Oncology Group
por: Kopp, Lisa M., et al.
Publicado: (2019)

A Review of Targeted Therapies Evaluated by the Pediatric Preclinical Testing Program for Osteosarcoma
por: Sampson, Valerie B., et al.
Publicado: (2013)

Tracking the Prevalence of FAS
por: Cordero, José F., et al.
Publicado: (1994)

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
Publicado: (1996)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020)

Differential Induction of Apoptosis by Fas–Fas Ligand Interactions in Human Monocytes and Macrophages
por: Kiener, Peter A., et al.
Publicado: (1997)

Understanding the role of Fas-Fas ligand system in bone
por: Marusic, Ana, et al.
Publicado: (2012)

Differential expressions of Fas and Fas ligand in human placenta.
por: Roh, Cheong-Rae, et al.
Publicado: (2002)

Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis
por: Bollain-y-Goytia, Juan José, et al.
Publicado: (2014)

The Fas/FasL System in Reproduction: Survival and Apoptosis
por: Mor, Gil, et al.
Publicado: (2002)

Impairment of Methotrexate Transport Is Common in Osteosarcoma Tumor Samples
por: Sowers, Rebecca, et al.
Publicado: (2011)

Role of Fas/FasL in regulation of inflammation in vaginal tissue during HSV-2 infection
por: Krzyzowska, M, et al.
Publicado: (2011)

Fas and Fas Ligand Interactions Suppress Melanoma Lung Metastasis
por: Owen-Schaub, Laurie B., et al.
Publicado: (1998)

Role of the Fas/FasL pathway in HIV or SIV disease
por: Poonia, Bhawna, et al.
Publicado: (2009)

Prognostic value of the Fas/Fas ligand system in breast cancer
por: Bębenek, Marek, et al.
Publicado: (2013)

Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
por: Volpe, Elisabetta, et al.
Publicado: (2016)

Membrane-bound but not Secreted Fas Ligand Is Essential for Fas-Induced Apoptosis and Prevention of Autoimmunity and Cancer
por: O' Reilly, Lorraine A., et al.
Publicado: (2009)

Fas Ligand (FasL) in Association with Tumor-Infiltrating Lymphocytes (TILs) in Early Stage Cervical Cancer
por: Anggraeni, Tricia Dewi, et al.
Publicado: (2020)

Fas/FasL Signaling Regulates CD8 Expression During Exposure to Self-Antigens
por: Flores-Mendoza, Giovanna, et al.
Publicado: (2021)

Knock down of Fas-Associated Protein with Death Domain (FADD) Sensitizes Osteosarcoma to TNFα-induced Cell Death
por: Hollomon, Mario G., et al.
Publicado: (2020)

Detection of circulating tumor DNA in patients with osteosarcoma
por: Barris, David M., et al.
Publicado: (2018)

Impaired Fas-Fas Ligand Interactions Result in Greater Recurrent Herpetic Stromal Keratitis in Mice
por: Yin, Xiao-Tang, et al.
Publicado: (2015)

FAS and FAS-Ligand Promoter Polymorphisms in Hepatitis B Virus Infection
por: Mohammadi, Asadollah, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_18nq8a1l0ktqo738ojfl1lrqdj